News
- Author:
- Lucy Hicks
Publish date: November 1, 2023
The drug has also been granted an interchangeability designation and has been approved for six indications.
News
- Author:
- Lucy Hicks
Publish date: November 1, 2023
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.
News
- Author:
- Lucy Hicks
Publish date: October 31, 2023
Histologic analysis did not sufficiently predict treatment response to certain medications, but gene expression and transcriptome analysis methods ...
News
- Author:
- Lucy Hicks
Publish date: October 30, 2023
“Mobile technologies, in particular, offer a nimble, customizable, and accessible way to reach this target population and increase awareness of PrE...
News
- Author:
- Lucy Hicks
Publish date: October 26, 2023
“I don’t know if this was intentional, but it seems suspicious that a product marketed to reduce joint pain and inflammation contains prescription-...
News
- Author:
- Lucy Hicks
Publish date: October 20, 2023
The discovery will hopefully lead to new therapeutic avenues for the condition, experts say.
News
- Author:
- Lucy Hicks
Publish date: October 12, 2023
The model, using patient characteristics as well as provider preferences, suggests when certain visits can be carried out via telehealth.
News
- Author:
- Lucy Hicks
Publish date: October 10, 2023
This new route of administration is expected to become available during the fourth quarter of 2023.
News
- Author:
- Lucy Hicks
Publish date: October 6, 2023
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several o...
News
- Author:
- Lucy Hicks
Publish date: October 6, 2023
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late Oct...
News
- Author:
- Lucy Hicks
Publish date: October 3, 2023
Patients with aortic inflammation detected by PET were at greater risk for developing aortic aneurysms, particularly thoracic aortic aneurysms.
News
- Author:
- Lucy Hicks
Publish date: October 3, 2023
Tocilizumab-bavi (Tofidence) will offer a lower-cost option for patients with autoimmune conditions, the drug manufacturer, Biogen, stated.
News
- Author:
- Lucy Hicks
Publish date: September 28, 2023
Promising results from small case studies and early clinical trials hint at the potential of CAR T-cell therapy to treat – and possibly cure – auto...
News
- Author:
- Lucy Hicks
Publish date: September 11, 2023
Patients taking colchicine had fewer gout flares than did those taking placebo for the first 6 months, but the number evened out between the two gr...
News
- Author:
- Lucy Hicks
Publish date: September 7, 2023
The test helps to determine if patients with rheumatoid arthritis are unlikely to respond to anti-TNF therapies.
